Chirag Shah, MD @CShahMD @ClevelandClinic @WhitworthMD @RRabinovitch @margenthalerj ASCO22 #OncoTwitter @oncoalert Assessing The Benefit Of AET

Chirag Shah, MD @CShahMD @ClevelandClinic @WhitworthMD @R...

Annual Meeting Photo
Annual Meeting
3 miesięcy
13 Wyświetleń
Chcesz obejrzeć to ponownie później ?
Zaloguj się, aby dodać ten film do listy odtwarzania Zaloguj
0 0

Chirag Shah, MD, Director of Breast Radiation Oncology and Director of Clinical Research in the Department of Radiation Oncology at Cleveland Clinic. In this video, he speaks about the ASCO 2022 Abstract - Assessing the benefit of adjuvant endocrine therapy in patients following breast-conserving surgery with or without radiation stratified by a 7-gene predictive DCIS biosignature.